These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9796859)

  • 1. 1H NMR conformational study on N-terminal nonapeptide sequences of HIV-1 Tat protein: a contribution to structure-activity relationships.
    Mrestani-Klaus C; Fengler A; Brandt W; Faust J; Wrenger S; Reinhold D; Ansorge S; Neubert K
    J Pept Sci; 1998 Sep; 4(6):400-10. PubMed ID: 9796859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth.
    Wrenger S; Hoffmann T; Faust J; Mrestani-Klaus C; Brandt W; Neubert K; Kraft M; Olek S; Frank R; Ansorge S; Reinhold D
    J Biol Chem; 1997 Nov; 272(48):30283-8. PubMed ID: 9374514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal HIV-1 Tat nonapeptides as inhibitors of dipeptidyl peptidase IV. Conformational characterization.
    Mrestani-Klaus C; Fengler A; Faust J; Brandt W; Wrenger S; Reinhold D; Ansorge S; Neubert K
    Adv Exp Med Biol; 2000; 477():125-9. PubMed ID: 10849738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nonapeptides derived from the N-terminal structure of human immunodeficiency virus-1 (HIV-1) Tat on suppression of CD26-dependent T cell growth.
    Wrenger S; Reinhold D; Faust J; Mrestani-Klaus C; Brandt W; Fengler A; Neubert K; Ansorge S
    Adv Exp Med Biol; 2000; 477():161-5. PubMed ID: 10849743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites.
    Lorey S; Stöckel-Maschek A; Faust J; Brandt W; Stiebitz B; Gorrell MD; Kähne T; Mrestani-Klaus C; Wrenger S; Reinhold D; Ansorge S; Neubert K
    Eur J Biochem; 2003 May; 270(10):2147-56. PubMed ID: 12752434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26).
    Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
    J Biol Chem; 2005 Apr; 280(15):14911-7. PubMed ID: 15695814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells.
    Wrenger S; Reinhold D; Hoffmann T; Kraft M; Frank R; Faust J; Neubert K; Ansorge S
    FEBS Lett; 1996 Apr; 383(3):145-9. PubMed ID: 8925885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation of N-terminal HIV-1 Tat (fragment 1-9) peptide by NMR and MD simulations.
    Kanyalkar M; Srivastava S; Coutinho E
    J Pept Sci; 2001 Nov; 7(11):579-87. PubMed ID: 11763362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete 1H nuclear magnetic resonance assignments and structural characterization of a fusion protein of the alpha-amylase inhibitor tendamistat with the activation domain of the human immunodeficiency virus type 1 Tat protein.
    Freund J; Vértesy L; Koller KP; Wolber V; Heintz D; Kalbitzer HR
    J Mol Biol; 1995 Jul; 250(5):672-88. PubMed ID: 7623384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein.
    Péloponèse JM; Grégoire C; Opi S; Esquieu D; Sturgis J; Lebrun E; Meurs E; Collette Y; Olive D; Aubertin AM; Witvrow M; Pannecouque C; De Clercq E; Bailly C; Lebreton J; Loret EP
    C R Acad Sci III; 2000 Oct; 323(10):883-94. PubMed ID: 11098404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectroscopic investigations of HIV-1 trans-activator and related peptides in aqueous solutions.
    Klostermeier D; Bayer P; Kraft M; Frank RW; Rösch P
    Biophys Chem; 1997 Jan; 63(2-3):87-96. PubMed ID: 9108685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Tat targets TAR: structure of the BIV peptide-RNA complex.
    Greenbaum NL
    Structure; 1996 Jan; 4(1):5-9. PubMed ID: 8805518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling.
    Baier-Bitterlich G; Tretiakova A; Richardson MW; Khalili K; Jameson B; Rappaport J
    Biomed Pharmacother; 1998; 52(10):421-30. PubMed ID: 9921410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor.
    Wrenger S; Faust J; Mrestani-Klaus C; Fengler A; Stockel-Maschek A; Lorey S; Kahne T; Brandt W; Neubert K; Ansorge S; Reinhold D
    J Biol Chem; 2000 Jul; 275(29):22180-6. PubMed ID: 10896952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein.
    Grégoire C; Péloponèse JM; Esquieu D; Opi S; Campbell G; Solomiac M; Lebrun E; Lebreton J; Loret EP
    Biopolymers; 2001; 62(6):324-35. PubMed ID: 11857271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy.
    Shojania S; O'Neil JD
    J Biol Chem; 2006 Mar; 281(13):8347-56. PubMed ID: 16423825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational heterogeneity in two regions of TAT results in structural variations of this protein as a function of HIV-1 isolates.
    Gregoire CJ; Loret EP
    J Biol Chem; 1996 Sep; 271(37):22641-6. PubMed ID: 8798435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1.
    Reddy MV; Desai M; Jeyapaul J; Prasad DD; Seshamma T; Palmeri D; Khan SA
    Oncogene; 1992 Sep; 7(9):1743-8. PubMed ID: 1501886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.
    Gutheil WG; Subramanyam M; Flentke GR; Sanford DG; Munoz E; Huber BT; Bachovchin WW
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6594-8. PubMed ID: 7912830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies of HIV-1 Tat protein.
    Bayer P; Kraft M; Ejchart A; Westendorp M; Frank R; Rösch P
    J Mol Biol; 1995 Apr; 247(4):529-35. PubMed ID: 7723010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.